Durvalumab (D) Tremelimumab (T) Plus Platinum-Etoposide (EP) in First-Line Extensive-Stage SCLC (ES-SCLC): Exploratory Analysis of Patients with Long-Term Clinical Benefit in CASPIAN
ONCOLOGY RESEARCH AND TREATMENT（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要